The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
about
Epidemiology of hepatitis C virus infectionHepatitis B virus and hepatitis C virus infection in healthcare workersHepatitis B virus infection in immigrant populationsHCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortalityEpidemiological burden estimates for pathologies with a nonconstant risk: an application to HCV in Italy according to age, Metavir score, and genotype: A systematic review and meta-analysisUse of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitisHealth policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy.Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in ItalyInvestigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus.Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?Impact of comorbidities on the severity of chronic hepatitis B at presentationThe burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population.Discrepancies between physician's perception of depression in HIV patients and self-reported CES-D-20 assessment: the DHIVA studyHepatitis C and diabetes: the inevitable coincidence?Treatment of chronic hepatitis C in elderly patients.Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection.Predictors for dose reduction of antiviral therapy in older patients infected with hepatitis C virus: a meta-regression analysis.Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection.GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection.Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in southern Italy, January 2012 to June 2013.Molecular diversity in irregular or refugee immigrant patients with HBV-genotype-E infection living in the metropolitan area of Naples.Influence of universal HBV vaccination on chronic HBV infection in Italy: Results of a cross-sectional multicenter study.Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy.Bacterial meningitis complicating the course of liver cirrhosis.Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care.Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C.Treatment rate and factors related to interferon-based treatment initiation for chronic hepatitis C in South Korea.Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases.The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr.Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection.Liver eosinophilic infiltrate is a significant finding in patients with chronic hepatitis C.Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C.Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.Unawareness of HBV infection among inpatients in a Southern Italian hospitalCharacteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy
P2860
Q22305500-4AB2F9B7-E140-4628-9AC9-3ADFA7530F49Q26765801-50B40139-AF8B-4441-B6BB-E52F33423735Q26771150-E162E101-65E3-4492-8B2E-ABA4ADE74932Q27488220-236E964A-04C3-498E-AA49-58012DBDC3BAQ30244326-B0E13BEA-29A5-4158-98B7-620DFC1BF2B9Q33394544-8849F414-CB8B-4170-B01D-AD92477A757DQ33800146-360D78A8-6AE7-4FC2-90C6-9FA6A46E5D9EQ33801300-27202FD2-1604-4BE7-B8B2-F6242C5421E5Q34420891-A7660259-05D3-4177-AEDC-24C24D50465FQ34424151-C65BF814-084A-4BBA-9ADC-332DF5A285C1Q35886670-DA053EA6-5D74-43AF-A285-C6F7E5406222Q36187833-149EA59E-D2EE-4F61-9380-6D3BAF481D34Q36519123-E7C623C2-B1CB-40F5-ABA2-4FB7391304BFQ37432092-669E7234-C5E7-449D-B64F-56CC0FE232D7Q37693926-D00EDD3A-69C8-412E-BC58-02D3E8885992Q37879701-8DA57C71-6C47-4EA8-8A93-B09574B0685EQ38160178-AF5C6F05-23E1-4F8F-B3D7-56BEFA4C35BDQ38233860-6C5F127B-916B-4CBF-8A27-02A16D73D584Q38235178-93847B81-F179-4191-8E43-0115ABCD82DCQ38237281-7AE1EB1A-DB04-4A66-B175-3D402230938DQ38952987-39BDF575-1C86-4FAF-9B69-53E01F750AB3Q39224652-9CB9AA42-0FF3-4D7A-B801-48724718CC17Q39419887-62516C65-EC43-4673-9F51-BB42BDD94C58Q39965299-9CFA11DE-7C38-41CE-9FA2-5961EA96A434Q40052458-E6C7CB3D-8D13-4FB9-9954-05533461C283Q40535279-EEE3E2D3-BE76-44D6-B4F1-137B48B6537EQ40580971-E5C68AFE-E9F5-4E61-9DE1-6E6FCB96FDD4Q41089743-5C7249F8-E366-4301-8F95-B0A8B0372F5FQ42999777-0E7DC60C-705F-46B4-972E-6FEE8B15DCB7Q43036906-D5E6A410-9B1D-4977-A977-60A774644448Q43047852-5279A1D1-EACB-4E02-ACF2-79DC9C32288FQ43433076-92ECE948-791B-4E55-9B09-FFFFC4F2C897Q43974244-566B8974-1B80-49BD-BC40-26B125882222Q45324819-D7439455-AD2D-4265-B3F1-B022C0216970Q47573260-81E7F15A-EFC3-42A8-B37F-2942564DC93DQ50189592-A61F43B9-12CC-4F15-8464-7A25281B0B3AQ50798940-DBA8DC1C-C455-4CC4-81C2-6E4AC6E50616Q57557330-14A0F0D2-450F-4D07-8D3D-5D8449407E8FQ57821731-B68C28DF-DE7D-4D3C-8C12-A8BD6B3BD43D
P2860
The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The importance of HCV on the b ...... evalence study of 9,997 cases.
@en
type
label
The importance of HCV on the b ...... evalence study of 9,997 cases.
@en
prefLabel
The importance of HCV on the b ...... evalence study of 9,997 cases.
@en
P2093
P50
P356
P1476
The importance of HCV on the b ...... revalence study of 9,997 cases
@en
P2093
Alfonso Mele
Carlo Scolastico
Luigina Ferrigno
Michele Imparato
Mirella Onofrio
Piero Almasio
P304
P356
10.1002/JMV.20313
P577
2005-04-01T00:00:00Z